the sySTEMs initiative : systems biology-augmented, stem cell-derived, multi-tissue panel for rapid screening of approved drugs as potential COVID-19 treatments
- Funded by Medical Research Future Fund (MRFF)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$736,387.33Funder
Medical Research Future Fund (MRFF)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Vaccines alone can't stop COVID-19 infections; we also need safe, effective and affordable COVID-19 treatments urgently. A great strategy is to repurpose drugs already approved for other diseases. To do that we need rapid, high-throughput drug screening in relevant tissues grown from 'stem cells'. However, this system needs improvement in its readouts, reproducibility and clinical correlation. We intend to achieve this and screen the 3 most promising repurposed drug candidates within a year.